Report Detail
Global Rivastigmine Oral Market Professional Survey Report 2019
- RnM3765993 |
- 20 September, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Rivastigmine (sold under the trade name Exelon) is a acetylcholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
The global Rivastigmine Oral market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Rivastigmine Oral volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rivastigmine Oral market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Rivastigmine Oral in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Rivastigmine Oral manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Novartis
Sun Pharmaceutical
Mylan Pharmaceuticals
Teva
Dr. Reddy's Laboratories
Orchid Healthcare
APOTEX
Alembic Pharmaceuticals
MACLEODS
Cadila Pharmaceuticals
Aurobindo Pharma
Ajanta Pharma
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
1.5 mg Capsules
3 mg Capsules
4.5 mg Capsules
6 mg Capsules
2mg/ml Oral solution
Segment by Application
Alzheimer's disease
Parkinson's
Table of Contents
Executive Summary
1 Industry Overview of Rivastigmine Oral
- 1.1 Definition of Rivastigmine Oral
- 1.2 Rivastigmine Oral Segment by Type
- 1.2.1 Global Rivastigmine Oral Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 1.5 mg Capsules
- 1.2.3 3 mg Capsules
- 1.2.4 4.5 mg Capsules
- 1.2.5 6 mg Capsules
- 1.2.6 2mg/ml Oral solution
- 1.3 Rivastigmine Oral Segment by Applications
- 1.3.1 Global Rivastigmine Oral Consumption Comparison by Applications (2014-2025)
- 1.3.2 Alzheimer's disease
- 1.3.3 Parkinson's
- 1.4 Global Rivastigmine Oral Overall Market
- 1.4.1 Global Rivastigmine Oral Revenue (2014-2025)
- 1.4.2 Global Rivastigmine Oral Production (2014-2025)
- 1.4.3 North America Rivastigmine Oral Status and Prospect (2014-2025)
- 1.4.4 Europe Rivastigmine Oral Status and Prospect (2014-2025)
- 1.4.5 China Rivastigmine Oral Status and Prospect (2014-2025)
- 1.4.6 Japan Rivastigmine Oral Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Rivastigmine Oral Status and Prospect (2014-2025)
- 1.4.8 India Rivastigmine Oral Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Rivastigmine Oral
- 2.3 Manufacturing Process Analysis of Rivastigmine Oral
- 2.4 Industry Chain Structure of Rivastigmine Oral
3 Development and Manufacturing Plants Analysis of Rivastigmine Oral
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Rivastigmine Oral Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Rivastigmine Oral
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Rivastigmine Oral Production and Capacity Analysis
- 4.2 Rivastigmine Oral Revenue Analysis
- 4.3 Rivastigmine Oral Price Analysis
- 4.4 Market Concentration Degree
5 Rivastigmine Oral Regional Market Analysis
- 5.1 Rivastigmine Oral Production by Regions
- 5.1.1 Global Rivastigmine Oral Production by Regions
- 5.1.2 Global Rivastigmine Oral Revenue by Regions
- 5.2 Rivastigmine Oral Consumption by Regions
- 5.3 North America Rivastigmine Oral Market Analysis
- 5.3.1 North America Rivastigmine Oral Production
- 5.3.2 North America Rivastigmine Oral Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Rivastigmine Oral Import and Export
- 5.4 Europe Rivastigmine Oral Market Analysis
- 5.4.1 Europe Rivastigmine Oral Production
- 5.4.2 Europe Rivastigmine Oral Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Rivastigmine Oral Import and Export
- 5.5 China Rivastigmine Oral Market Analysis
- 5.5.1 China Rivastigmine Oral Production
- 5.5.2 China Rivastigmine Oral Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Rivastigmine Oral Import and Export
- 5.6 Japan Rivastigmine Oral Market Analysis
- 5.6.1 Japan Rivastigmine Oral Production
- 5.6.2 Japan Rivastigmine Oral Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Rivastigmine Oral Import and Export
- 5.7 Southeast Asia Rivastigmine Oral Market Analysis
- 5.7.1 Southeast Asia Rivastigmine Oral Production
- 5.7.2 Southeast Asia Rivastigmine Oral Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Rivastigmine Oral Import and Export
- 5.8 India Rivastigmine Oral Market Analysis
- 5.8.1 India Rivastigmine Oral Production
- 5.8.2 India Rivastigmine Oral Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Rivastigmine Oral Import and Export
6 Rivastigmine Oral Segment Market Analysis (by Type)
- 6.1 Global Rivastigmine Oral Production by Type
- 6.2 Global Rivastigmine Oral Revenue by Type
- 6.3 Rivastigmine Oral Price by Type
7 Rivastigmine Oral Segment Market Analysis (by Application)
- 7.1 Global Rivastigmine Oral Consumption by Application
- 7.2 Global Rivastigmine Oral Consumption Market Share by Application (2014-2019)
8 Rivastigmine Oral Major Manufacturers Analysis
- 8.1 Novartis
- 8.1.1 Novartis Rivastigmine Oral Production Sites and Area Served
- 8.1.2 Novartis Product Introduction, Application and Specification
- 8.1.3 Novartis Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Sun Pharmaceutical
- 8.2.1 Sun Pharmaceutical Rivastigmine Oral Production Sites and Area Served
- 8.2.2 Sun Pharmaceutical Product Introduction, Application and Specification
- 8.2.3 Sun Pharmaceutical Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Mylan Pharmaceuticals
- 8.3.1 Mylan Pharmaceuticals Rivastigmine Oral Production Sites and Area Served
- 8.3.2 Mylan Pharmaceuticals Product Introduction, Application and Specification
- 8.3.3 Mylan Pharmaceuticals Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Teva
- 8.4.1 Teva Rivastigmine Oral Production Sites and Area Served
- 8.4.2 Teva Product Introduction, Application and Specification
- 8.4.3 Teva Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Dr. Reddy's Laboratories
- 8.5.1 Dr. Reddy's Laboratories Rivastigmine Oral Production Sites and Area Served
- 8.5.2 Dr. Reddy's Laboratories Product Introduction, Application and Specification
- 8.5.3 Dr. Reddy's Laboratories Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Orchid Healthcare
- 8.6.1 Orchid Healthcare Rivastigmine Oral Production Sites and Area Served
- 8.6.2 Orchid Healthcare Product Introduction, Application and Specification
- 8.6.3 Orchid Healthcare Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 APOTEX
- 8.7.1 APOTEX Rivastigmine Oral Production Sites and Area Served
- 8.7.2 APOTEX Product Introduction, Application and Specification
- 8.7.3 APOTEX Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Alembic Pharmaceuticals
- 8.8.1 Alembic Pharmaceuticals Rivastigmine Oral Production Sites and Area Served
- 8.8.2 Alembic Pharmaceuticals Product Introduction, Application and Specification
- 8.8.3 Alembic Pharmaceuticals Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 MACLEODS
- 8.9.1 MACLEODS Rivastigmine Oral Production Sites and Area Served
- 8.9.2 MACLEODS Product Introduction, Application and Specification
- 8.9.3 MACLEODS Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Cadila Pharmaceuticals
- 8.10.1 Cadila Pharmaceuticals Rivastigmine Oral Production Sites and Area Served
- 8.10.2 Cadila Pharmaceuticals Product Introduction, Application and Specification
- 8.10.3 Cadila Pharmaceuticals Rivastigmine Oral Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Aurobindo Pharma
- 8.12 Ajanta Pharma
9 Development Trend of Analysis of Rivastigmine Oral Market
- 9.1 Global Rivastigmine Oral Market Trend Analysis
- 9.1.1 Global Rivastigmine Oral Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Rivastigmine Oral Regional Market Trend
- 9.2.1 North America Rivastigmine Oral Forecast 2019-2025
- 9.2.2 Europe Rivastigmine Oral Forecast 2019-2025
- 9.2.3 China Rivastigmine Oral Forecast 2019-2025
- 9.2.4 Japan Rivastigmine Oral Forecast 2019-2025
- 9.2.5 Southeast Asia Rivastigmine Oral Forecast 2019-2025
- 9.2.6 India Rivastigmine Oral Forecast 2019-2025
- 9.3 Rivastigmine Oral Market Trend (Product Type)
- 9.4 Rivastigmine Oral Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Rivastigmine Oral Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Rivastigmine Oral. Industry analysis & Market Report on Rivastigmine Oral is a syndicated market report, published as Global Rivastigmine Oral Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Rivastigmine Oral market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
